Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Alison Goate

Icahn School of Medicine at Mount Sinai, Department: Psychiatry

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Denali Therapeutics

Disclosed Value
Listed Reason
Payment for services (e.g., consulting fees, honoraria, paid authorship)

Dr. Alison Goate (the study investigator that oversees banking of specimens) receives financial compensation as an advisory board member for Denali Therapeutics (a company that develops treatments for Alzheimer’s Disease).

Listed Research Project
Alzheimer's Disease Research Center

The Mount Sinai Alzheimer Disease Research Center (MSADRC) is committed to using innovative approaches and new technologies to understand, treat, and ultimately prevent the earliest signs of cognitive impairment due to Alzheimer's disease (AD) and other dementias. Also, the basic, translational, and clinical resources will be aligned to explore the controversial intersection between Type 2 diabetes and AD. These two conditions are common and understanding underlying the commonalities in their pathogenetic mechanisms may lead to improved treatments for one or both diseases. To date, the MSADRC has made seminal contributions to therapeutic development in AD research and the proposed work holds equally great promise for discoveries that will change the fate of those suffering from AD as well as those at risk.

Filed on December 06, 2018.

Tell us what you know about Alison Goate's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Alison Goate Icahn School of Medicine at Mount Sinai Conflict of Interest Denali Therapeutics $10,000 - $19,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page